Get proven high performance air purification and sterilisation with the world’s leading clean air system. Designed to ensure healthy airflow in all critical and non critical care environments.
VIRUSKILLER™ sterilises the widest range of airborne pathogens to 99.9999% efficiency in a single air-pass with zero emissions or irradiation.
Patient & staff safety
VIRUSKILLER™ puts clean, sterilised air into the breathing zone, reducing airborne transmission in high traffic areas. Tested against Sars-Cov-2 to 99.9999% inactivated, reducing airborne Covid-19 in hospitals. Single air pass kill means significant reduction of surface settlement. Adequate ventilation is accepted as key part of reducing airborne pathogens: VIRUSKILLER™ ventilates and sterilises air.
Healthcare environment
Can be installed ‘stand-alone’ in any area of hospital or healthcare facility. Can be incorporated into positive or negative pressure rooms. Bolsters air cleansing of existing systems – sterilising the air to a much higher efficacy than HEPA alone. No emissions, and low noise.
Airborne pathogens
The patented PCO technology has an impressive 17 year pedigree of tackling airborne pathogens in hospitals. 99.9999% (6-log) kill of microbes and deactivation of viruses. Effective against Sars-Cov-2 (Covid-19), along with Adenovirus, Influenza, Pseudomonas, Polio and more. Eliminates Staphylococcus Aureus (including MRSA) & Myobacterium Tuberculosis – problematic hospital bacteria.
Economics
Low cost of acquisition / low capital cost. Available via flexible commercial solution – fixed quarterly /monthly arrangement. Low running costs. Easily relocatable, hence VIRUSKILLER™ inventory can flexibly be redeployed if necessary in identified problematic areas. Significantly reduces the financial impact of HAI’s.
The National Health Service spends 1 billion each year as a result of nosocomial infections
UK in-hospital infections has risen from 5,972 in 2008 to 48,815 in 2017
Infection varies between 3.5% and 12% in developed countries
Approximately 30% of patients in ICU’s are affected by at least one episode of healthcare associated infection
Economic impact of HAI’s in Europe is estimated at approximately 7 billion pounds
Airborne transmission of pathogens accounts for 16 million additional days of hospital care
Designed to decontaminate sick, toxic and dirty air - realtime
Much great work is already done in hospitals to control hospital acquired infections (HAI’s). Disinfecting surfaces & good hygiene practices form a large part of the battle against HAI’s.
So, what about the pathogen droplets that become aerosolised? Recent medical literature states that organic matter can be located as far as 3-4m away from the origin and can be detected over 24 hours post treatment. The Radic8 solution was successfully designed specifically to solve the airborne problem.
VIRUSKILLER™ neutralises the widest range of airborne contaminants, pathogens & pollutants
Radic8 units help solve the challenge of:
Sars-Cov-2 (Covid-19) is airborne and surface transmitted.
Tuberculosis (Mycobacterium tuberculosis) is transmitted in the air and can be a source of outbreak in hospital.
Norovirus is transmitted by aerosol and is difficult to contain in a hospital ward.
Clostridium difficile spores are thought to spread in the air and can be found near a patient carrying the organism.
MRSA can be transmitted in aerosol from the respiratory tract.
Neutralising pathogens and airborne contaminants up to 165 m2
A 16 Year Success Story
VIRUSKILLER™ core technology was initially funded by the South Korean Government after the 2003 SARS epidemic. For the past 16 years the technology has been focused on killing airborne viruses and has successfully been introduced into over 80% of hospitals, lung examination rooms and, universities within South Korea to date.
Single air pass sterilisation is achieved via patented PCO (photocatalytic oxidation) chamber technology, similar to that used in the international space station.
The ‘reactor chamber’ is what sets VIRUSKILLER™ apart from any other comparable clean air system.
Air is drawn through a pre-filter, a carbon filter and a HEPA filter, before going to the reactor chamber
All particles are neutralised through the process. Clean air is directed to breathing zones ready for consumption
The VIRUSKILLER™ Reactor Chamber contains patented technology to maximise the germicidal photocatalytic action while remaining completely safe for consumer use.
The specialised design of the Reactor Chamber increases the power of the UV-C radiation multiple times through reflection and refraction, while our titanium dioxide (TiO2) surface preparation method ensures optimal reaction conditions. This ensures the only meaningful by-products formed are trace amounts of harmless water and CO2.
(Click to enlarge)
VIRUSKILLER™ patented PCO technology has ‘always on’ air sterilisation with 99.9999% efficiency achieving greater results than just HEPA filters alone.
Designed for medically sensitive environments the VK Medi is the world’s leading clean air solution.
In positive pressure rooms such as operating theatres VIRUSKILLER ™ can be located as a stand-alone unit, bolstering the existing air system. Alternatively, it can be installed into your air inlet, sterilising the air on the way in.
Negative pressure rooms in isolation or containment areas ‘exhaust’ high contaminant air out. VIRUSKILLER™can be used to ensure you don’t just move sick air, you kill it on the way out.
Multi layered filter system
Robust fan integration
Sterilisation PCO reactor chamber
Exacting UV-C light process
Air flow confinement
No harmful emissions
Pulls contaminated air down towards the floor and into the prescribed unit
Releases clean, safe air out at the prescribed breathing level in a single pass for the appropriate nature of care and environmental considerations
Talk to our safe-air for medical specialists
Average rate for a complete air exchange in a normal sized surgical room is between 4-6 minutes. Example VK401 Flow rate is 141 CFM - room size 564ft3
